The Team Behind Clinical Genomics Intelligence

Julie Kines is Director of Laboratory Operations & Quality at Simplify Genomics, where she oversees laboratory operations, sequencing workflows, quality systems, and scalable genomic production infrastructure. Julie was part of the operational leadership team that helped build and manage the whole genome sequencing laboratory environment at Human Longevity, contributing directly to the large-scale genomic processing capabilities that formed the foundation of the original platform.

With nearly two decades of experience in molecular diagnostics, next-generation sequencing, and laboratory quality management, Julie has led high-throughput sequencing operations across clinical, research, and public health environments. Prior to joining Simplify Genomics, she served as WGS Lab Manager at Human Longevity, where she managed whole genome sequencing operations and helped operationalize scalable sequencing workflows supporting large-volume genomic analysis. Before Human Longevity, Julie held leadership roles at Genoptix, where she supervised next-generation sequencing operations for clinical molecular testing.

At Simplify Genomics, Julie continues to lead and modernize the sequencing and operational systems originally developed at Human Longevity — ensuring the platform remains actively supported, continuously improved, and capable of meeting the demands of modern clinical genomics. Her expertise spans laboratory quality systems, assay validation, workflow automation, regulatory compliance, and operational scaling for whole genome sequencing environments.

Julie’s leadership has been instrumental in building reliable, production-grade genomic operations capable of delivering high-quality genomic data at scale. As part of the core team that originally helped operationalize the platform over years of clinical deployment, she brings deep institutional knowledge and operational continuity that continues to drive the evolution of Simplify Genomics’ technology and laboratory infrastructure.

Anita Kuusela, PhD, is the Director of Genomics at Simplify Genomics, where she leads scientific strategy, genomic interpretation, and clinical content development across the company’s reporting and analysis platforms. Anita was a key member of the scientific leadership team responsible for building and operationalizing the genomic interpretation infrastructure originally developed at Human Longevity, helping establish scalable methods for transforming whole genome data into clinically actionable insights.

With deep expertise in human genetics, variant interpretation, and clinical genomics, Anita has spent more than a decade developing genomic reporting systems designed for real-world clinical deployment. Prior to Simplify Genomics, she served as Principal Genomic Scientist at Human Longevity, where she played a central role in the development of interpretation workflows, clinical curation standards, and genome analysis pipelines supporting large-scale whole genome reporting.

At Simplify Genomics, Anita continues to lead the evolution of the same foundational genomics platform and scientific framework originally developed at Human Longevity — now modernized, expanded, and actively supported by the core scientific and technical team that built it. Under her leadership, Simplify Genomics has scaled the interpretation and curation of thousands of genes and millions of genomic variants across hereditary disease, pharmacogenomics, polygenic risk, and wellness applications.

Anita’s work focuses on bridging advanced genomic science with scalable clinical implementation, ensuring that complex genomic information can be delivered in a format that is accurate, actionable, and operationally sustainable. Her leadership has been instrumental in developing automated interpretation systems that reduce turnaround time while maintaining rigorous scientific and clinical standards.

As part of the founding team, Anita continues to advance the technology, processes, and scientific knowledge base originally established over years of clinical genome reporting — enabling healthcare organizations, laboratories, and physicians to deploy whole genome interpretation at scale with confidence and continuity.

Henry Tsai, MD, PhD, is Laboratory Director at Simplify Genomics, where he oversees clinical laboratory operations, regulatory compliance, quality management systems, and medical governance for the company’s genomic testing platform. Dr. Tsai previously served as Laboratory Director at Human Longevity, where he played a central role in establishing and maintaining the clinical and regulatory framework supporting large-scale genomic testing and reporting operations.

Board-certified in Anatomic Pathology, Clinical Pathology, and Cytopathology, Dr. Tsai brings extensive expertise in clinical laboratory oversight, molecular diagnostics, CAP and CLIA compliance, laboratory accreditation, and medical quality systems. His career has focused on building clinically rigorous laboratory environments capable of supporting high-throughput genomic testing while meeting the demanding standards required for clinical deployment and patient care.

At Simplify Genomics, Dr. Tsai continues to oversee and advance the compliance and quality infrastructure originally developed during the Human Longevity era — ensuring the platform remains actively governed, clinically validated, and aligned with evolving regulatory and accreditation requirements. Under his leadership, Simplify Genomics successfully achieved College of American Pathologists (CAP) accreditation, reinforcing the company’s commitment to clinical excellence, operational rigor, and high-quality genomic reporting.

Dr. Tsai earned his MD and PhD in Pharmacology and Toxicology from the University of California, Irvine, before completing residency and fellowship training at UCLA in Anatomic and Clinical Pathology, Surgical Pathology, and Cytopathology. Throughout his career, he has held multiple laboratory directorship and medical oversight roles across molecular diagnostics, oncology, and genomic medicine organizations, including Human Longevity and NeoGenomics.

As part of the founding clinical leadership team at Simplify Genomics, Dr. Tsai provides the medical oversight, compliance expertise, and operational continuity necessary to support modern clinical genomics at scale — ensuring that the technology and laboratory systems originally developed over years of deployment continue to evolve under experienced clinical leadership.

Erik Wahlstrom is Director of DevOps and Information Security at Simplify Genomics, where he leads the cloud infrastructure, security architecture, and operational systems that support the company’s genomic data platforms. He was part of the core technical team behind the secure systems architecture originally developed at Human Longevity, helping establish the operational foundation that continues to support large-scale clinical genomics.

Erik’s work sits at the intersection of distributed systems, cloud operations, cybersecurity, identity, and data protection. He has built and secured platforms in regulated enterprise environments, with experience spanning authentication and authorization, API security, machine identity, compliance operations, and large-scale protection of sensitive data. This background helps Simplify Genomics maintain the security, reliability, and governance required for modern precision medicine.

At Simplify Genomics, Erik continues to evolve and modernize the platform’s infrastructure so it remains secure, resilient, actively supported, and ready for continued scale. His work complements the company’s genomics, laboratory, data systems, and clinical leadership by ensuring that the underlying technical environment can support trusted analysis, interpretation, and delivery of genomic information.

Erik’s role also extends into hands-on full-stack engineering, particularly where genomic data, clinical workflows, compliance requirements, and secure cloud operations intersect. He works across application, data, and infrastructure layers to turn business and clinical needs into reliable software systems. He brings the ability to elicit workflows from users and stakeholders, identify underlying requirements and constraints, and carry solutions through technical design, implementation, infrastructure, and operation.

Erik also drives how Simplify Genomics incorporates AI into its engineering practice. His focus is on the methods that make AI useful beyond isolated tasks: preserving context, carrying forward technical artifacts, capturing decisions, and applying those disciplines across application development, DevOps, and infrastructure. This has helped shape a development model in which a small technical team can move quickly while maintaining continuity, rigor, and software quality.